Carbapenem-Resistant Gram-Negative Bacilli Bacteremia in Argentina (EMBARCAR): Findings From a Prospective, Multicenter Cohort Study
Clinical Infectious Diseases · 24.12.2025 · 81 (5) · 879-888
DOI: 10.1093/cid/ciaf259 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Clinical Infectious Diseases, online erschienen am 20.05.2025. Verfasst von Juan Pablo Balbuena und 33 weiteren Autor:innen. Beteiligte Einrichtung: Department of Research and Infectious Diseases Service, Instituto Médico Platense, La Plata, Argentina. Hauptthemen laut MEDLINE: Bacteremia, Anti-Bacterial Agents, Carbapenems, Gram-Negative Bacteria. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 37 Literaturangaben.
Abstract (Originalsprache)
Background
Bloodstream infections (BSIs) caused by carbapenem-resistant gram-negative bacilli (CR-GNB) are difficult-to-treat infections associated with high mortality. Outcomes of BSI due to CR-GNB may vary in different countries.
Methods
Prospective observational, multicenter study, including consecutive hospitalized index patients aged ≥18 years, with a positive blood culture for CR-GNB, between July 2020 and March 2022 in Argentina. Among patients with Klebsiella pneumoniae BSIs, logistic regressions adjusted by propensity score (PS) were used to identify variables associated with 30-day mortality.
Results
Overall, 466 patients with CR-GNB BSIs were included. The mean age was 56.7 (SD ±16) years and most patients (75%) were in critical care units. The median INCREMENT-CPE mortality score was 10 (IQR, 6–12). Most common micro-organisms were K pneumoniae (53%) and Acinetobacter baumannii (25%). Among Enterobacterales, resistance mechanisms included K pneumoniae carbapenemase (KPC) in 50%, metallo-beta-lactamase carbapenemase (MBL) in 48%, OXA carbapenemase in 6%, and a combination of carbapenemases in 5% of patients. Overall, 30-day mortality was 52%. Among patients with BSI due to K pneumoniae, the PS-adjusted multivariate analysis showed that an INCREMENT-CPE score ≥8 points (odds ratio [OR], 3.48; 95% CI, 1.53, 7.93) was associated with increased 30-day mortality. In contrast, the use of regimens including ceftazidime-avibactam alone or in combination with aztreonam was associated with decreased 30-day mortality (OR, .20; 95% CI, .09, .47).
Conclusions
BSIs due to CR-GNB are associated with high mortality rates in Argentina. Among patients with CR-K pneumoniae bacteremia the use of ceftazidime-avibactam alone or in combination with aztreonam was associated with a reduction in mortality.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Research and Infectious Diseases Service, Instituto Médico Platense, La Plata, Argentina.
- Infectious Diseases Unit (EC, MIL) and Department of Medicine (CS), Hospital General De Agudos Dr. Cosme Argerich, Buenos Aires, Argentina.
- Infectious Diseases Service, Hospital Cuenca Alta Nestor Kirchner, Cañuelas, Argentina.
- Infectious Diseases Service, Hospital Higa Evita, Lanús, Argentina.
- Infectious Diseases Unit, Hospital Santojanni, Buenos Aires, Argentina.
- Infectious Diseases Service, Sanatorio Británico, Rosario, Argentina.
ORCID-Profile: Juan Pablo Balbuena, Ezequiel Cordova, Javier Farina, María Inés Lespada, Esteban Nannini, Rosa Contreras, Eleonora Cunto, Fernando Pasteran, Claudia Salgueira, Martin Hojman, Miriam Blanco, Horacio Lopez Alegre, William E Cox Fernandez, Dario Godoy, Maria A Biglia, Maria J Lopez Furst, Gustavo A Mendez, Fernando Pálizas, Romina Cardone, Milagro Sanchez Cunto, Gabriel Perez, Cesar Sanchez, Martin E Stryjewski
Zitieren
APA
Balbuena, J. P., Cordova, E., Mykietiuk, A., Farina, J., Gañete, M., Scapellato, P., Lespada, M. I., Nannini, E., Contreras, R., Cunto, E., Barcelona, L., Pasteran, F., Salgueira, C., Hojman, M., Blanco, M., Lopez Alegre, H., Cox Fernandez, W. E., Ezcurra, C., Godoy, D., …, & Stryjewski, M. E. (2025). Carbapenem-Resistant Gram-Negative Bacilli Bacteremia in Argentina (EMBARCAR): Findings From a Prospective, Multicenter Cohort Study. Clinical Infectious Diseases, 81(5), 879-888. https://doi.org/10.1093/cid/ciaf259
Vancouver
Balbuena JP, Cordova E, Mykietiuk A, Farina J, Gañete M, Scapellato P, et al. Carbapenem-Resistant Gram-Negative Bacilli Bacteremia in Argentina (EMBARCAR): Findings From a Prospective, Multicenter Cohort Study. Clinical Infectious Diseases. 2025;81(5):879-888. doi:10.1093/cid/ciaf259
BibTeX
@article{Balbuena2025,
author = {Balbuena, Juan Pablo and Cordova, Ezequiel and Mykietiuk, Analia and Farina, Javier and Gañete, Marcelo and Scapellato, Pablo and Lespada, María Inés and Nannini, Esteban and Contreras, Rosa and Cunto, Eleonora and Barcelona, Laura and Pasteran, Fernando and Salgueira, Claudia and Hojman, Martin and Blanco, Miriam and Lopez Alegre, Horacio and Cox Fernandez, William E and Ezcurra, Cecilia and Godoy, Dario and Biglia, Maria A and Lopez Furst, Maria J and Mendez, Gustavo A and Aguirre Rios, Maria F and Messina, Oscar and Ciappina, Antonella and Pálizas, Fernando and Altclas, Javier and Gaudenzi, Giuliano and Cardone, Romina and Sanchez Cunto, Milagro and Ruiz, Mariquena and Perez, Gabriel and Sanchez, Cesar and Stryjewski, Martin E},
title = {Carbapenem-Resistant Gram-Negative Bacilli Bacteremia in Argentina (EMBARCAR): Findings From a Prospective, Multicenter Cohort Study},
journal = {Clinical Infectious Diseases},
year = {2025},
volume = {81},
number = {5},
pages = {879--888},
doi = {10.1093/cid/ciaf259}
}
EUVIMED